China National Chemical Engineering (601117) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
5 Dec, 2025Executive summary
Achieved total operating revenue of ¥90.42 billion, down 0.21% year-over-year; net profit attributable to shareholders rose 9.26% to ¥3.10 billion.
Gross margin improved to 9.57%; basic and diluted EPS both increased to ¥0.51, up 10.87% year-over-year.
New contract value reached ¥206.09 billion, up 1.24% year-over-year, with international contracts growing 0.36%.
Main business segments include chemical engineering, infrastructure, environmental management, new materials, and modern services.
Financial highlights
Operating income: ¥90.42 billion (down 0.21% year-over-year).
Net profit attributable to shareholders: ¥3.10 billion (up 9.26% year-over-year).
Total assets: ¥237.67 billion (up 1.82% from year-end 2024).
Net assets attributable to shareholders: ¥65.49 billion (up 5.16% from year-end 2024).
Operating cash flow: -¥10.03 billion (down from -¥4.57 billion year-over-year).
Non-recurring profit and loss: ¥99.09 million.
Outlook and guidance
Company expects continued growth in international markets and further expansion in high-end chemical engineering and new materials.
Focus on technological innovation, digital transformation, and risk management to drive high-quality development.
Dividend proposal: cash dividend of ¥1.0 per 10 shares, representing 19.69% of net profit for the period, pending shareholder approval.
Latest events from China National Chemical Engineering
- Net profit up 13.15% to ¥6.44B, with record new contracts and strong overseas growth.601117
H2 202525 Mar 2026 - Revenue and net profit rose over 4% year-over-year, driven by strong new contracts and overseas growth.601117
H2 202418 Dec 2025 - Net profit grew 10.28% year-over-year to RMB 4.23 billion on rising revenue and new contracts.601117
Q3 202530 Oct 2025 - Q3 net profit surged 28.57% year-over-year, but operating cash flow turned negative.601117
Q3 202413 Jun 2025 - Revenue and profit declined, but gross margin and new contracts improved in H1 2024.601117
H1 202413 Jun 2025 - Net profit surged 18.77% in Q1 2025 despite a slight revenue dip and negative cash flow.601117
Q1 20256 Jun 2025